IceCure Medical (ICCM) Accumulated Depreciation & Amortization (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Accumulated Depreciation & Amortization data on file, last reported at $1.8 million in Q4 2025.

• Accumulated Depreciation & Amortization for Q4 2025 came in at $1.8 million, up 16.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (up 16.7% YoY), and the FY2025 annual result was $1.8 million, up 16.7% from the prior year.
• Accumulated Depreciation & Amortization rose to $1.8 million in Q4 2025 per ICCM's latest filing, from $1.6 million in the prior quarter.
• Over five years, Accumulated Depreciation & Amortization peaked at $1.8 million in Q4 2025 and troughed at $127000.0 in Q4 2021.
• A 5-year average of $991000.0 and a median of $1.2 million in 2023 frame the typical range for Accumulated Depreciation & Amortization.
• The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation & Amortization jumped 391.53% in 2023, then gained 16.7% in 2025.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $127000.0 in 2021, then jumped by 95.28% to $248000.0 in 2022, then jumped by 391.53% to $1.2 million in 2023, then grew by 27.24% to $1.6 million in 2024, then grew by 16.7% to $1.8 million in 2025.
• Business Quant data shows ICCM's Accumulated Depreciation & Amortization at $1.8 million in Q4 2025, $1.6 million in Q4 2024, and $1.2 million in Q4 2023.